BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25451058)

  • 1. Hydroxylated tropolones inhibit hepatitis B virus replication by blocking viral ribonuclease H activity.
    Lu G; Lomonosova E; Cheng X; Moran EA; Meyers MJ; Le Grice SF; Thomas CJ; Jiang JK; Meck C; Hirsch DR; D'Erasmo MP; Suyabatmaz DM; Murelli RP; Tavis JE
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1070-9. PubMed ID: 25451058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity.
    Hu Y; Cheng X; Cao F; Huang A; Tavis JE
    Antiviral Res; 2013 Sep; 99(3):221-9. PubMed ID: 23796982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and cytotoxicity in cell culture of novel α-hydroxytropolone inhibitors of hepatitis B virus ribonuclease H.
    Lomonosova E; Daw J; Garimallaprabhakaran AK; Agyemang NB; Ashani Y; Murelli RP; Tavis JE
    Antiviral Res; 2017 Aug; 144():164-172. PubMed ID: 28633989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic α-Hydroxytropolones Inhibit Replication of Wild-Type and Acyclovir-Resistant Herpes Simplex Viruses.
    Ireland PJ; Tavis JE; D'Erasmo MP; Hirsch DR; Murelli RP; Cadiz MM; Patel BS; Gupta AK; Edwards TC; Korom M; Moran EA; Morrison LA
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2140-9. PubMed ID: 26787704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity.
    Cai CW; Lomonosova E; Moran EA; Cheng X; Patel KB; Bailly F; Cotelle P; Meyers MJ; Tavis JE
    Antiviral Res; 2014 Aug; 108():48-55. PubMed ID: 24858512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitors.
    Lu G; Villa JA; Donlin MJ; Edwards TC; Cheng X; Heier RF; Meyers MJ; Tavis JE
    Antiviral Res; 2016 Nov; 135():24-30. PubMed ID: 27693161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes.
    Tavis JE; Cheng X; Hu Y; Totten M; Cao F; Michailidis E; Aurora R; Meyers MJ; Jacobsen EJ; Parniak MA; Sarafianos SG
    PLoS Pathog; 2013 Jan; 9(1):e1003125. PubMed ID: 23349632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication.
    Li Q; Lomonosova E; Donlin MJ; Cao F; O'Dea A; Milleson B; Berkowitz AJ; Baucom JC; Stasiak JP; Schiavone DV; Abdelmessih RG; Lyubimova A; Fraboni AJ; Bejcek LP; Villa JA; Gallicchio E; Murelli RP; Tavis JE
    Antiviral Res; 2020 May; 177():104777. PubMed ID: 32217151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hepatitis B virus ribonuclease H as a drug target.
    Tavis JE; Lomonosova E
    Antiviral Res; 2015 Jun; 118():132-8. PubMed ID: 25862291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Enzymatic and Cell Culture-Based Assays for Measuring Activity of HBV RNaseH Inhibitors.
    Lomonosova E; Tavis JE
    Methods Mol Biol; 2017; 1540():179-192. PubMed ID: 27975316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical Approaches to Inhibiting the Hepatitis B Virus Ribonuclease H.
    Tavis JE; Zoidis G; Meyers MJ; Murelli RP
    ACS Infect Dis; 2019 May; 5(5):655-658. PubMed ID: 29565562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles.
    Edwards TC; Lomonosova E; Patel JA; Li Q; Villa JA; Gupta AK; Morrison LA; Bailly F; Cotelle P; Giannakopoulou E; Zoidis G; Tavis JE
    Antiviral Res; 2017 Jul; 143():205-217. PubMed ID: 28450058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Troponoids on Mitochondrial Function and Cytotoxicity.
    Bradley DP; O'Dea AT; Woodson ME; Li Q; Ponzar NL; Knier A; Rogers BL; Murelli RP; Tavis JE
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0161721. PubMed ID: 34694883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Interactions between Hepatitis B Virus RNase H Antagonists and Other Inhibitors.
    Lomonosova E; Zlotnick A; Tavis JE
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HBV replication by N-hydroxyisoquinolinedione and N-hydroxypyridinedione ribonuclease H inhibitors.
    Edwards TC; Mani N; Dorsey B; Kakarla R; Rijnbrand R; Sofia MJ; Tavis JE
    Antiviral Res; 2019 Apr; 164():70-80. PubMed ID: 30768944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric mice.
    Long KR; Lomonosova E; Li Q; Ponzar NL; Villa JA; Touchette E; Rapp S; Liley RM; Murelli RP; Grigoryan A; Buller RM; Wilson L; Bial J; Sagartz JE; Tavis JE
    Antiviral Res; 2018 Jan; 149():41-47. PubMed ID: 29129708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Inhibition of Hepatitis B Virus (HBV) Replication and cccDNA Formation by HBV Ribonuclease H Inhibitors during Infection.
    Chauhan R; Li Q; Woodson ME; Gasonoo M; Meyers MJ; Tavis JE
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0146021. PubMed ID: 34516242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease H.
    Huber AD; Michailidis E; Tang J; Puray-Chavez MN; Boftsi M; Wolf JJ; Boschert KN; Sheridan MA; Leslie MD; Kirby KA; Singh K; Mitsuya H; Parniak MA; Wang Z; Sarafianos SG
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
    Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T
    J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitors.
    Villa JA; Pike DP; Patel KB; Lomonosova E; Lu G; Abdulqader R; Tavis JE
    Antiviral Res; 2016 Aug; 132():186-95. PubMed ID: 27321664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.